ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
40,003.59
0.34%
Gold vs US Dollar
2,413.935
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,902.57
-0.27%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ocuphire Pharma Inc (OCUP)

  7. Ocuphire Pharma Inc (OCUP) News

Ocuphire Pharma (OCUP)

Ocuphire Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OCUP
DateTimeSourceHeadlineSymbolCompany
10/05/202421:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OCUPOcuphire Pharma Inc
10/05/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCUPOcuphire Pharma Inc
10/05/202413:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCUPOcuphire Pharma Inc
08/03/202422:20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:OCUPOcuphire Pharma Inc
08/03/202413:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCUPOcuphire Pharma Inc
16/02/202421:31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:OCUPOcuphire Pharma Inc
16/02/202421:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCUPOcuphire Pharma Inc
14/02/202423:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
14/02/202423:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
14/02/202423:32Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
14/02/202423:29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
24/01/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OCUPOcuphire Pharma Inc
22/01/202423:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
22/01/202423:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
12/01/202421:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
12/01/202421:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
12/01/202421:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
11/01/202421:16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:OCUPOcuphire Pharma Inc
10/01/202422:00Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OCUPOcuphire Pharma Inc
03/01/202423:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
03/01/202423:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
03/01/202423:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
03/01/202422:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
05/12/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
27/11/202313:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCUPOcuphire Pharma Inc
13/11/202322:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
13/11/202322:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
13/11/202313:48Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OCUPOcuphire Pharma Inc
13/11/202313:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCUPOcuphire Pharma Inc
03/11/202313:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:OCUP

Your Recent History

BIT
UC3JRL
Unicredit Bank
COIN
CCTCBTC
USOTC
OVATF
Ovation Science (QB)
UNSW
ALNETH
Aluna
BIT
UB1C6V
Unicredit Bank
KUCN
TRYBTC
Trias Token
COIN
MINGBP
TSXV
BER.H
BE Resources
NYSE
TWO
Two Harbors Investment
LSE
IMG
Imagination Technologies
BOV
ELETE362
ELETE362 Ex:35,85
COIN
PKTBTC
Playkey
BOV
GOLL4
GOL PN
LSE
AUK
Aukett Swanke
NYSE
SSTK
Shutterstock
TSX
CGX
Cineplex
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved